Clinical Trials
3 trialsNCT04015700 2026-05-07
Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma
Washington University School of Medicine
Phase 1 Active not recruiting
NCT04367675 2026-02-23
INO 5401 Vaccination in BRCA1/2 Mutation Carriers
Abramson Cancer Center at Penn Medicine
Phase 1 Active not recruiting
NCT03439085 2024-07-09
DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers
M.D. Anderson Cancer Center
Phase 2 Terminated